RecruitingPhase 1NCT06717269

Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets

A Phase 1, Open-Label Study in Healthy Volunteers to Evaluate the Relative Bioavailability of NX-5948 Tablets Compared to Capsules, and the Effect of Food and an Acid-reducing Agent on the Pharmacokinetics of NX-5948

Sponsor

Nurix Therapeutics, Inc.

Enrollment

18 participants

Start Date

Nov 30, 2024

Study Type

INTERVENTIONAL

Conditions

Healthy Volunteer

Summary

This is a multiple part, multiple cohort study evaluating the relative bioavailability, food effect, and drug-drug interaction of NX-5948 in healthy volunteers.

Eligibility

Min Age: 19 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Esomeprazole and a drug called NX-5948 for people with healthy volunteer. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.